e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
COPD: notable points
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD
Ekaterina Kochetova (Petrozavodsk, Republic of Karelia, Russian Federation), Ekaterina Kochetova
Source:
International Congress 2015 – COPD: notable points
Session:
COPD: notable points
Session type:
Poster Discussion
Number:
4798
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ekaterina Kochetova (Petrozavodsk, Republic of Karelia, Russian Federation), Ekaterina Kochetova. Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 4798
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
The influence of O
2
on exercise capacity (6-minute-walking-distance, 6MWD) in COPD
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Heart rate recovery after 6-min walk test predicts acute exacerbation in COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Negative pressure ventilation decreases lung function decline, acute exacerbations and hospitalizations in COPD patients with desaturation during 6 minute walk test
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
CAT in COPD phenotypes (POPE study)
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept